Global Diabetic Retinopathy Market Share Report 2024, Forecast To 2033

The diabetic retinopathy market has demonstrated robust growth, increasing from $7.89 billion in 2023 to $8.56 billion in 2024, with a compound annual growth rate (CAGR) of 8.5%. This growth can be attributed to factors such as the aging population, the rising prevalence of diabetes, and improved healthcare infrastructure facilitating greater awareness and diagnosis of diabetic retinopathy. Looking ahead, the market is expected to maintain strong growth, reaching $11.4 billion by 2028, with a CAGR of 7.4%. Factors driving this growth include personalized medicine approaches, the expansion of telemedicine services, and the development of novel therapeutic interventions. Additionally, the adoption of point-of-care testing and remote patient monitoring further contribute to market expansion. Major trends in the forecast period include precision medicine in diabetic retinopathy treatment, an increased focus on early detection and prevention, and the growth of teleophthalmology services. Furthermore, advancements in retinal imaging technology and ongoing gene therapy research are expected to shape the market landscape.